Clinical Trials Directory

Trials / Terminated

TerminatedNCT01320475

Epidural Levobupivacaine-sufentanil Versus Epidural Levobupivacaine and Intravenous Ketamine

Thoracic Epidural Analgesia: Epidural Levobupivacaine and Sufentanil Versus Epidural Levobupivacaine and Intravenous Ketamine

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
2 (actual)
Sponsor
Hopital Foch · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Thoracic epidural analgesia is often proposed to thoracotomized patients. A local anesthetic and an opioid are generally associated to produce an epidural analgesia. However, opioid epidural administration is frequently associated with adverse effects as nausea, vomiting, urinary retention, ... On the other hand, iv ketamine has been demonstrated to be an effective analgesic. The purpose of the study is to compare the epidural administration of levobupivacaine and sufentanil or the epidural administration of levobupivacaine associated with the iv administration of ketamine.

Conditions

Interventions

TypeNameDescription
DRUGSufentanilEpidural infusion of levobupivacaine (1,25 mg/ml) and sufentanil(1 ml = 50 µg diluted in the 200 ml bag of levobupivacaine) IV infusion of saline (placebo for ketamine)
DRUGKetamineEpidural infusion of levobupivacaine (1,25 mg/ml) and saline (1 ml = 50 µg diluted in the 200 ml bag of levobupivacaine) IV infusion of ketamine (2 µg/kg/minute) Up to the third postoperative day (6 PM)

Timeline

Start date
2010-09-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2011-03-22
Last updated
2016-09-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01320475. Inclusion in this directory is not an endorsement.